Profile of non-compliance in lymphoblastic leukaemia (Q35254934)

7 August 2017

Profile of non-compliance in lymphoblastic leukaemia (English)

1 reference

7 August 2017

1 reference

Lancaster D

1

1 reference

7 August 2017

Lennard L

series ordinal

2

1 reference

7 August 2017

Lilleyman JS

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Archives of Disease in Childhood

7 August 2017

1 reference

7 August 2017

76

1 reference

7 August 2017

4

1 reference

7 August 2017

365-366

1 reference

Non-compliance with oral chemotherapy in childhood leukaemia

7 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717135

Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?

27 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1717135

Compliance of pediatric and adolescent cancer patients

27 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9166035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9166035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9166035

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ADC.76.4.365

1 reference

7 August 2017

1 reference

7 August 2017

1 reference